Ajibade Ashaye

516 total citations
36 papers, 337 citations indexed

About

Ajibade Ashaye is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ajibade Ashaye has authored 36 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Internal Medicine and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ajibade Ashaye's work include Venous Thromboembolism Diagnosis and Management (10 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Acute Lymphoblastic Leukemia research (6 papers). Ajibade Ashaye is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (10 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Acute Lymphoblastic Leukemia research (6 papers). Ajibade Ashaye collaborates with scholars based in United States, United Kingdom and Spain. Ajibade Ashaye's co-authors include Luc Djoussé, J. Michael Gaziano, Craig I Coleman, Jeffrey Kluger, Alexander T. Cohen, Nathan R. Hill, Xuemei Luo, X Li, L. Vo and Cristina Masseria and has published in prestigious journals such as Blood, Annals of Internal Medicine and The American Journal of Cardiology.

In The Last Decade

Ajibade Ashaye

29 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ajibade Ashaye United States	10	169	109	43	40	35	36	337
Surya Mohanty United States	6	156 0.9×	88 0.8×	11 0.3×	19 0.5×	43 1.2×	9	279
A. Groth Germany	12	386 2.3×	117 1.1×	12 0.3×	26 0.7×	67 1.9×	25	626
Birgitte Klindt Poulsen Denmark	8	150 0.9×	82 0.8×	8 0.2×	28 0.7×	45 1.3×	18	270
Brynja R. Guðmundsdóttir Iceland	11	156 0.9×	109 1.0×	37 0.9×	10 0.3×	7 0.2×	30	318
Pål Falck Norway	10	94 0.6×	50 0.5×	13 0.3×	91 2.3×	7 0.2×	12	345
Kevin M. Wheelock United States	11	86 0.5×	40 0.4×	46 1.1×	19 0.5×	5 0.1×	16	313
Morten Olesen Denmark	11	436 2.6×	39 0.4×	20 0.5×	9 0.2×	52 1.5×	33	655
Juan Carlos Claro Chile	8	85 0.5×	60 0.6×	14 0.3×	20 0.5×	5 0.1×	14	311
Piotr Adamski Poland	13	439 2.6×	109 1.0×	16 0.4×	5 0.1×	14 0.4×	40	577
Thomas Andersen Rix Denmark	8	183 1.1×	26 0.2×	30 0.7×	6 0.1×	14 0.4×	12	332

Countries citing papers authored by Ajibade Ashaye

Since Specialization

Citations

This map shows the geographic impact of Ajibade Ashaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajibade Ashaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajibade Ashaye more than expected).

Fields of papers citing papers by Ajibade Ashaye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ajibade Ashaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajibade Ashaye. The network helps show where Ajibade Ashaye may publish in the future.

Co-authorship network of co-authors of Ajibade Ashaye

This figure shows the co-authorship network connecting the top 25 collaborators of Ajibade Ashaye. A scholar is included among the top collaborators of Ajibade Ashaye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ajibade Ashaye. Ajibade Ashaye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghosh, Susmita, et al.. (2025). 1985P Comparative effectiveness of first-line (1L) tyrosine kinase inhibitors (TKIs) in ALK+ metastatic NSCLC (mNSCLC) by presence of brain metastases (BM). Annals of Oncology. 36. S1053–S1054.

Ashaye, Ajibade, Ling Shi, Ibrahim Aldoss, et al.. (2025). Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial. Leukemia. 39(6). 1342–1350.

Drummond, Mark W., Carlo Finelli, Fjoralba Kristo, et al.. (2025). Real-World Treatment Patterns, Clinical Outcomes, and Costs in Patients with Higher-Risk Myelodysplastic Syndromes Across France, Germany, and the United Kingdom. Journal of Blood Medicine. Volume 16. 307–319.

García‐Gutiérrez, Valentín, Fei Huang, Ajibade Ashaye, et al.. (2024). Ponatinib vs. asciminib in post–second-generation tyrosine kinase inhibitor therapy for chronic-phase chronic myeloid leukemia: a matching-adjusted indirect comparison. Frontiers in Oncology. 14. 1455378–1455378. 2 indexed citations

Kristo, Fjoralba, Antoine Regnault, Justin Ferdinandus, et al.. (2024). Patient-Reported Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Advanced-Stage Classical Hodgkin Lymphoma Treated with BrECADD and eBEACOPP in the HD21 Trial. Blood. 144(Supplement 1). 1662–1662.

Ashaye, Ajibade, Yves Chalandon, Hervé Dombret, et al.. (2023). Minimal Residual Disease-Negative Complete Remission at the End of Induction Is a Prognostic Indicator of Long-Term Survival in Adult Patients with Ph+ Acute Lymphoblastic Leukemia Receiving First-Line Therapy. Blood. 142(Supplement 1). 6075–6075.

Ashaye, Ajibade, Mehul Dalal, Vamsi Kota, et al.. (2022). Patient preferences for frontline therapies for Philadelphia chromosome-positive acute lymphoblastic leukemia: a discrete choice experiment. Future Oncology. 18(17). 2075–2085. 4 indexed citations

Hill, Nathan R., Belinda Sandler, Dušan Milenković, et al.. (2020). A Systematic Review of Network Meta-Analyses and Real-World Evidence Comparing Apixaban and Rivaroxaban in Nonvalvular Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis. 26. 2873297292–2873297292. 17 indexed citations

Cohen, Alexander T., et al.. (2018). A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants. International Journal of Cardiology. 269. 174–181. 47 indexed citations

10.

Ashaye, Ajibade, et al.. (2015). Estimating Eortc-8d Health State Utility Values From Eortc Qlq-C30 Scores In Relapsed Multiple Myeloma. Value in Health. 18(7). A468–A468. 1 indexed citations

11.

Ashaye, Ajibade, et al.. (2015). Mapping Utility Scores from European organization for Treatment of Cancer Core-30 Questionnaire Scores (Eortc Qlq-C30) In Relapsed Multiple Myeloma. Value in Health. 18(3). A208–A208. 1 indexed citations

12.

Liu, Enchi, Ajibade Ashaye, Karin Travers, et al.. (2014). P1‐147: A PROSPECTIVE, SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSES TO EVALUATE GLOBAL AND REGIONAL BRAIN VOLUMES BY STRUCTURAL MRI AS BIOMARKERS OF ALZHEIMER'S DISEASE (AD) PROGRESSION. Alzheimer s & Dementia. 10(4S_Part_9).

13.

Byrnes, Michael, Ajibade Ashaye, Ike Iheanacho, Karin Travers, & Mirko Sikirica. (2013). Mortality and Survival in Inoperable or Residual/Recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Literature Review. Value in Health. 16(7). A378–A378. 1 indexed citations

14.

Talati, Ripple, William L. Baker, Ajibade Ashaye, et al.. (2012). Efficacy and Safety of Innovator versus Generic Drugs in Patients with Epilepsy: A Systematic Review. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 32(4). 314–322. 25 indexed citations

15.

Chen, Wendy, Soyon Lee, Jennifer Colby, et al.. (2012). The Impact of Pre-Transplant Red Blood Cell Transfusions in Renal Allograft Rejection. 5 indexed citations

16.

Akinkuolie, Akintunde O., Megan Aleardi, Ajibade Ashaye, J. Michael Gaziano, & Luc Djoussé. (2012). Height and Risk of Heart Failure in the Physicians' Health Study. The American Journal of Cardiology. 109(7). 994–997. 15 indexed citations

17.

White, C Michael, Olivia J Phung, Jeffrey Kluger, et al.. (2011). Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review. International Journal of Clinical Practice. 65(7). 749–763. 4 indexed citations

18.

Sobieraj, Diana M, C Michael White, Jeffrey Kluger, et al.. (2011). Systematic review: comparative effectiveness of adjunctive devices in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention of native vessels. BMC Cardiovascular Disorders. 11(1). 74–74. 2 indexed citations

19.

White, C Michael, Olivia J Phung, Jeffrey Kluger, et al.. (2011). Association Between CHADS2 Risk Factors and Anticoagulation-Related Bleeding: A Systematic Literature Review. Mayo Clinic Proceedings. 86(6). 509–521. 9 indexed citations

20.

Ashaye, Ajibade, J. Michael Gaziano, & Luc Djoussé. (2010). Red meat consumption and risk of heart failure in male physicians. Nutrition Metabolism and Cardiovascular Diseases. 21(12). 941–946. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact